Related Experiment Video
Updated: Mar 29, 2026

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Published on: May 9, 2018
SERUM AND BAL YKL-40 LEVELS IN DIFFERENT INFLAMMATORY LUNG DISEASES: AN UPDATE
M Filippelli1, C Cuppari2, V Giacchi1
1Department of Clinical and Experimental Medicine, Unit of Broncho-Pneumology and Cystic Fibrosis, University of Catania, Catania, Italy.
YKL-40, a protein linked to inflammation and fibrosis, may serve as a biomarker for diagnosing and monitoring lung diseases. Further research is needed to clarify its role in pulmonary conditions.
Area of Science:
- Biochemistry
- Immunology
- Pulmonology
Background:
- YKL-40 (chitinase 3-like-1) is a glycosyl hydrolase family 18 protein.
- It functions as a pro-inflammatory cytokine involved in tissue remodeling and fibrosis.
- Its specific role in pulmonary diseases remains largely undetermined.
Purpose of the Study:
- To review the literature on YKL-40's function in lung diseases.
- To assess YKL-40 as a potential biomarker for pulmonary inflammation and fibrosis.
- To consolidate current understanding of YKL-40 in respiratory pathology.
Main Methods:
- Comprehensive literature search of PubMed database.
- Keywords: YKL-40, chitinase 3-like-1, pulmonary diseases, inflammation, fibrosis.
- Inclusion criteria: English articles published since 1997, search conducted in October 2014.
Main Results:
- YKL-40 is implicated in pathological tissue remodeling and fibrosis in various diseases.
- Evidence suggests YKL-40's involvement in inflammatory processes.
- The precise pathophysiological significance of YKL-40 in lung diseases requires further elucidation.
Conclusions:
- YKL-40 shows potential as a biomarker for diagnosing and monitoring lung diseases.
- Its role in inflammation and fibrosis in pulmonary conditions warrants continued investigation.
- Further studies are essential to validate YKL-40's utility in clinical practice for respiratory diseases.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024